Changing to core biopsy in an NHS breast screening unit

Autor: A. H. Freeman, Ruchi Sinnatamby, Peter Britton, L. Bobrow, M.J. Goddard, D.G.D. Wight, Ruth Warren, Christopher D.R. Flower
Rok vydání: 1997
Předmět:
Zdroj: Clinical Radiology. 52:764-767
ISSN: 0009-9260
DOI: 10.1016/s0009-9260(97)80156-0
Popis: We recently changed from using fine needle aspiration cytology to using core biopsy exclusively in the assessment of screen detected abnormalities. Two hundred and two biopsies (1% of women screened) were performed. Surgical histological confirmation was obtained in 111 patients (101 malignant and 10 benign). The remaining patients were either returned to standard 3-yearly screening or early repeat screening after 1 year. Analysis of the results was performed in accordance with the standards specified in the National Health Service Breast Screening Programme (NHSBSP) Publication Number 22. Absolute sensitivity was 89.3%, complete sensitivity was 93.2%, specificity (including patients undergoing both surgical excision and follow-up) was 88.7%. The predictive value of a positive (malignant) core biopsy result was 100%. The false negative rate was 3.9%. Twelve (5.9%) biopsies were classified inadequate for diagnosis. Core biopsy is a safe and accurate way of assessing screen detected abnormalities and can be used as a substitute for fine needle aspiration cytology with results that exceed the National Health Service Breast Screening Programme target standards, even in the learning phase.
Databáze: OpenAIRE